Researchers at Lucy Therapeutics Inc. have identified new adenosine receptor agonists...

PTC Therapeutics Inc. has patented new NLRP3 inflammasome inhibitors reported to be useful...

Insilico Medicine IP Ltd. has synthesized membrane-associated tyrosine- and threonine-specific Cdc2-inhibitory kinase (PKMYT1) inhibitors reported to be useful for the treatment of cancer.

Merck Sharp & Dohme Corp. has disclosed adenosine A2A (ADORA2A) and/or A2B (ADORA2B) receptor antagonists reported to be useful for the treatment of cancer.

Sichuan Haisco Pharmaceutical Co. Ltd. has described N6-adenosine-methyltransferase catalytic subunit (METTL3) inhibitors reported to be useful for the treatment of cancer.

Arbutus Biopharma Corp. has divulged RNA polymerase inhibitors reported to be useful for the treatment of coronavirus infection.

Bayer AG has identified fused pyrimidines GTPase KRAS (G12D mutant) inhibitors reported to be useful for the treatment of cancer.

Novartis AG has synthesized glucagon-like peptide 1 receptor (GLP-1R) agonists reported to be useful for the treatment of type 2 diabetes, obesity, hypertension, stroke, hyperglycemia, dyslipidemia, nonalcoholic steatohepatitis and diabetic nephropathy, among others.

Canwell Biotech Ltd. has disclosed drug conjugates comprising tissue-binding small...

Etern Biopharma (Shanghai) Co. Ltd. has described bicyclic heteroaryl compounds acting as transcriptional coactivator YAP1 and/or TAZ/transcriptional enhancer factor (TEAD) interaction inhibitors reported to be useful for the treatment of cancer, fibrosis and cardiovascular disorders.